CD8A and neoplasm: Inhibiting specific TAN phenotypes: P2RX1-negative neutrophils in liver metastases correlate with PD-L1 expression; their inhibition activates CD8+ T cell anti-tumor immunity, suppressing pancreatic cancer progression.